Bank of America upgraded shares of Clorox (NYSE:CLX) from an underperform rating to a neutral rating in a research report released on Thursday, January 4th, MarketBeat Ratings reports. The brokerage currently has $155.00 price objective on the stock.

A number of other brokerages have also commented on CLX. Zacks Investment Research lowered Clorox from a hold rating to a sell rating in a report on Wednesday, October 4th. Jefferies Group restated a hold rating and set a $132.00 target price (down previously from $137.00) on shares of Clorox in a research note on Friday, October 6th. Morgan Stanley decreased their target price on Clorox from $138.00 to $128.00 and set an equal weight rating for the company in a research note on Thursday, November 2nd. Consumer Edge upgraded Clorox from a neutral rating to an outperform rating in a research note on Friday, November 10th. Finally, BMO Capital Markets restated a buy rating and set a $150.00 target price on shares of Clorox in a research note on Thursday, October 5th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the company’s stock. Clorox has an average rating of Hold and a consensus price target of $134.19.

Shares of Clorox (CLX) traded up $1.06 during midday trading on Thursday, hitting $142.02. The stock had a trading volume of 208,738 shares, compared to its average volume of 828,073. The company has a debt-to-equity ratio of 3.02, a quick ratio of 0.77 and a current ratio of 1.10. The firm has a market cap of $18,391.80, a price-to-earnings ratio of 26.03, a price-to-earnings-growth ratio of 3.73 and a beta of 0.42. Clorox has a fifty-two week low of $119.57 and a fifty-two week high of $150.40.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, beating the Zacks’ consensus estimate of $1.41 by $0.05. The business had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.48 billion. Clorox had a return on equity of 161.59% and a net margin of 11.84%. The firm’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.36 EPS. analysts predict that Clorox will post 5.71 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be given a $0.84 dividend. The ex-dividend date is Tuesday, January 23rd. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.37%. Clorox’s dividend payout ratio is currently 61.88%.

In related news, SVP Matthew T. Laszlo sold 20,051 shares of the firm’s stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total transaction of $2,615,853.46. Following the completion of the transaction, the senior vice president now owns 10,896 shares in the company, valued at approximately $1,421,492.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Michael R. Costello sold 10,574 shares of the firm’s stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total value of $1,438,169.74. Following the transaction, the senior vice president now owns 34,867 shares of the company’s stock, valued at approximately $4,742,260.67. The disclosure for this sale can be found here. 1.00% of the stock is currently owned by company insiders.

Institutional investors have recently bought and sold shares of the stock. Victory Capital Management Inc. increased its holdings in Clorox by 19.8% during the 2nd quarter. Victory Capital Management Inc. now owns 19,414 shares of the company’s stock valued at $2,587,000 after purchasing an additional 3,206 shares in the last quarter. Pacer Advisors Inc. increased its holdings in Clorox by 8.3% during the 2nd quarter. Pacer Advisors Inc. now owns 2,642 shares of the company’s stock valued at $352,000 after purchasing an additional 203 shares in the last quarter. Cipher Capital LP acquired a new stake in Clorox during the 2nd quarter valued at $974,000. State of Tennessee Treasury Department increased its holdings in Clorox by 3.3% during the 2nd quarter. State of Tennessee Treasury Department now owns 79,920 shares of the company’s stock valued at $10,649,000 after purchasing an additional 2,554 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in Clorox by 0.6% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 9,569 shares of the company’s stock valued at $1,275,000 after purchasing an additional 54 shares in the last quarter. Institutional investors and hedge funds own 73.20% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Clorox (CLX) Raised to Neutral at Bank of America” was first reported by Marea Informative and is the property of of Marea Informative. If you are accessing this piece on another site, it was stolen and republished in violation of U.S. & international trademark and copyright law. The legal version of this piece can be viewed at https://www.mareainformativa.com/2018/01/30/clorox-clx-upgraded-at-bank-of-america-updated-updated-updated.html.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.